— Know what they know.
Not Investment Advice

YI NASDAQ

111, Inc.
1W: -10.0% 1M: -6.9% 3M: -17.6% YTD: +17.4% 1Y: -29.6% 3Y: -87.0% 5Y: -94.7%
$3.22
-0.09 (-2.57%)
 
Weekly Expected Move ±9.1%
$3 $3 $3 $4 $4
NASDAQ · Healthcare · Medical - Distribution · Tech Score Sell · Power 40 · $28.1M mcap · 9M float · 0.224% daily turnover · Short 13% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$14.4B -3.7% ▼
5Y CAGR: +29.5%
Gross Profit
$829M +84.9% ▲
5Y CAGR: +38.1%
Operating Income
$2M +100.6% ▲
Net Income
-$65M +83.5% ▲
EPS (Diluted)
$-7.52 +83.9% ▲
EBITDA
$25M +107.9% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$8.2B$12.4B$13.5B$14.9B$14.4B
YoY Growth+107.6%+51.5%+8.8%+10.6%-3.7%
Cost of Revenue$7.8B$11.8B$12.7B$14.5B$13.6B
Gross Profit$366M$621M$840M$448M$829M
Gross Margin4.5%5.0%6.2%3.0%5.8%
R&D Expenses$92M$189M$140M$0$0
SG&A Expenses$528M$720M$664M$673M$385M
Operating Expenses$839M$1.3B$1.2B$799M$827M
Operating Income-$473M-$642M-$371M-$350M$2M
Operating Margin-5.8%-5.2%-2.7%-2.3%0.0%
Interest Expense$9M$5M$13M$20M$28M
Income Before Tax-$467M-$621M-$376M-$353M-$21M
Tax Expense$0$0$0$251K$96K
Net Income-$457M-$670M-$417M-$393M-$65M
Net Margin-5.6%-5.4%-3.1%-2.6%-0.4%
EPS (Diluted)$-55.40$-80.76$-50.04$-46.58$-7.52
EBITDA-$459M-$588M-$322M-$311M$25M
Shares Outstanding8M8M8M8M9M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms